Terapéutica génica y farmacogenómica
TerGenOMIC
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (6)
2022
-
Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
HLA, Vol. 99, Núm. 2, pp. 93-104
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
High-throughput genotyping of HLA-G, HLA-F, MICA, and MICB and analysis of frequency distributions in healthy blood donors from Catalonia
HLA, Vol. 97, Núm. 5, pp. 420-427
-
SARS-CoV-2/COVID-19 pandemic: First wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report
Blood Transfusion, Vol. 19, Núm. 2, pp. 158-167
2018
-
Design and Validation of a Multiplex KIR and HLA Class I Genotyping Method Using Next Generation Sequencing
Frontiers in Immunology, Vol. 9